Skip to content

Cell-free Tumor DNA (cfDNA) Quantitative Analysis Using Fluorescence In Situ Hybridization (FISH) Probe

Published: August 9, 2026Updated: August 16, 2026

This test measures small fragments of DNA released by cancer cells into your bloodstream. It helps detect genetic changes associated with certain cancers.

Quick summary

["This test may help monitor cancer progression or response to treatment by tracking DNA changes in your blood."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
88131-8
Short code
CMV DNA Ocflu Ql NAA+probe
Synonyms
CMV DNA Ocflu Ql NAA+probe
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
probe-amp-tar
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Does This Test Measure?

The test analyzes tiny pieces of DNA (called cell-free DNA or cfDNA) found in your blood. These fragments come from both healthy and cancerous cells. The FISH probe targets specific genetic regions to detect abnormalities, such as gene amplifications or deletions, that may indicate cancer.

Why Might This Test Be Ordered?

Your healthcare provider may recommend this test if you have a known cancer diagnosis or are at high risk for certain cancers. It can also be used to monitor treatment effectiveness or check for recurrence by looking for persistent genetic changes in your blood.

Sample Collection and Preparation

A blood sample is drawn from a vein in your arm. The blood is processed to isolate cell-free DNA, which is then tested using the FISH probe method. This process helps identify specific genetic markers without needing a biopsy.

What Does a Positive or Negative Result Mean?

A positive result may show genetic changes linked to cancer, but it doesn’t confirm cancer alone. Results are interpreted alongside clinical findings, imaging, and other tests. A negative result means no detectable genetic changes were found in this sample, but further testing may still be needed.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

This test is particularly useful for cancers where genetic mutations are known to drive progression, such as certain types of lung, breast, or colorectal cancers. It can provide early detection or monitoring without invasive procedures, helping guide treatment decisions and track disease activity over time.

Short name

cfDNA FISH Probe Test

Frequently asked questions

What are the possible reasons for ordering this test?
This test may be ordered to assess for genetic changes in cancer cells, monitor treatment response, or check for cancer recurrence in patients with known cancer diagnoses.
How long does it take to get results from this test?
Results are typically available within 1 to 2 weeks, depending on laboratory processing times and any additional confirmatory testing required.
Is this test painful or uncomfortable?
The blood draw is generally mild discomfort for a few minutes, similar to other routine blood tests. Most people tolerate it well, and you can resume normal activities afterward.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy